Search

Your search keyword '"Claudia Menzaghi"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Claudia Menzaghi" Remove constraint Author: "Claudia Menzaghi" Topic internal medicine Remove constraint Topic: internal medicine
47 results on '"Claudia Menzaghi"'

Search Results

2. The Synergic Association of hs-CRP and Serum Amyloid P Component in Predicting All-Cause Mortality in Patients With Type 2 Diabetes

Catalog

Books, media, physical & digital resources

3. Circulating Metabolites Associate With and Improve the Prediction of All-Cause Mortality in Type 2 Diabetes

5. A Serum Resistin and Multicytokine Inflammatory Pathway Is Linked with and Helps Predict All-cause Death in Diabetes

6. Circulating Adiponectin Levels Are Paradoxically Associated With Mortality Rate: A Systematic Review and Meta-Analysis

7. The Adiponectin Paradox for All-Cause and Cardiovascular Mortality

8. 1610-P: On the Combined Effect of C-Reactive Protein (CRP) and Serum Amyloid Component P (SAP) on Mortality Risk in Type 2 Diabetes

9. The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: Evidence of synergism with abdominal adiposity

10. Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model

11. The Adiponectin-Mortality Paradox—A Systematic Review and Meta-analysis

12. Suggestive evidence of a multi-cytokine resistin pathway in humans and its role on cardiovascular events in high-risk individuals

13. Joint effect of insulin signaling genes on all-cause mortality

14. Role of obesity on all-cause mortality in whites with type 2 diabetes from Italy

15. Development and Validation of a Predicting Model of All-Cause Mortality in Patients With Type 2 Diabetes

16. Letter by Menzaghi et al regarding article, 'plasma levels of fatty acid-binding protein 4, retinol-binding protein 4, high-molecular-weight adiponectin, and cardiovascular mortality among men with type 2 diabetes: A 22-year prospective study'

17. Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence

18. Relationship between ADIPOQ gene, circulating high molecular weight adiponectin and albuminuria in individuals with normal kidney function: evidence from a family-based study

19. Erratum. The Adiponectin Paradox for All-Cause and Cardiovascular Mortality. Diabetes 2018;67:12–22

20. Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family-based study

21. Evidence of a causal relationship between high serum adiponectin levels and increased cardiovascular mortality rate in patients with type 2 diabetes

22. The paradoxical association of adiponectin with mortality rate in patients with type 2 diabetes: evidence of synergism with kidney function

23. Strong evidence of sexual dimorphic effect of adiposity excess on insulin sensitivity

24. Heritability of Serum Resistin and Its Genetic Correlation with Insulin Resistance-Related Features in Nondiabetic Caucasians

25. Association between Resistin Levels and All-Cause and Cardiovascular Mortality: A New Study and a Systematic Review and Meta-Analysis

26. Serum resistin and glomerular filtration rate in patients with type 2 diabetes

27. Serum adiponectin and glomerular filtration rate in patients with type 2 diabetes

28. COMMENT: Genetic Variability in Insulin Action Inhibitor Ikkβ (IKBKB) Does Not Play a Major Role in the Development of Type 2 Diabetes

29. Low prevalence of HNF1A mutations after molecular screening of multiple MODY genes in 58 Italian families recruited in the pediatric or adult diabetes clinic from a single Italian hospital

30. Circulating adiponectin and cardiovascular mortality in patients with type 2 diabetes mellitus: evidence of sexual dimorphism

31. Clinical heterogeneity of abnormal glucose homeostasis associated with the HNF4A R311H mutation

32. Genetics of serum resistin: a paradigm of population-specific regulation?

33. Graves’ Immunoglobulins Activate Phospholipase A2by Recognizing Specific Epitopes on Thyrotropin Receptor1

34. Association Between an R338L Mutation in the Thyroid Hormone Receptor-β Gene and Thyrotoxic Features in Two Unrelated Kindreds with Resistance to Thyroid Hormone

35. Cyclooxygenase-Dependent Thyroid Cell Proliferation Induced by Immunoglobulins from Patients with Graves’ Disease1

36. GALNT2 expression is reduced in patients with Type 2 diabetes: possible role of hyperglycemia

37. Serum Resistin and Kidney Function: A Family-Based Study in Non-Diabetic, Untreated Individuals

38. Novel Locus FER Is Associated With Serum HMW Adiponectin Levels

39. The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells

40. ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells

41. The protein tyrosine phosphatase receptor type f (PTPRF) locus is associated with coronary artery disease in type 2 diabetes

42. The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction

43. Lack of evidence for interaction between APM1 and PPARgamma2 genes in modulating insulin sensitivity in nondiabetic Caucasians from Italy

44. Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13

45. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients

46. PO5-126 COMBINED EFFECT OF K121Q OF ENPP1 (PC-1) AND Q84R OF TRIB3 ON AGE AT MYOCARDIAL INFARCTION IN TYPE 2 DIABETIC PATIENTS

47. Corrigenda